.png)
Regenerative Therapies
Regenerative medicine is a fast-moving field where genuine science sits alongside aggressive, sometimes unsubstantiated marketing. Patients encounter bold claims that are hard to evaluate, and clinicians face the challenge of separating evidence-based application from hype. Without a grounded, evidence-informed framework, both overpromising and missed opportunity are real risks — and the person seeking help is left unsure who to trust.
Also known as
HBOT, hyperbaric oxygen, neuromodulation, PRP, platelet-rich plasma, stem cell, IV therapy, neurostimulation, tDCS, TMS, photobiomodulation
ICD-10
Z51.89 (Other specified aftercare), M96.89 (Other postprocedural musculoskeletal disorders)
How focused education closes the gap
Clinicians grounded in the science can apply regenerative approaches responsibly and in context.- Assess where regenerative approaches are genuinely indicated and evidence-supported- Identify the realistic role of these therapies within a broader care plan- Translate current evidence into measured, honest patient guidance
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
Alternating Currents in Neuromodulation
Elevate your neuromodulation skills. Learn to apply Professor Carrick’s protocols to optimize brain activity, mood, motor output, and autonomic function.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
Exploring Hyperbaric Oxygen in Clinical Practice
A clinician-focused introduction to hyperbaric oxygen therapy, exploring pressure physiology, cellular mechanisms, safety, and practical applications for inflammation, neuroprotection, metabolic recovery, and complex patient care.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
HBOT Research: Mild vs High Pressure
A 1-credit ISCN lecture examining new research comparing mild and high-pressure hyperbaric oxygen therapy and its implications for clinical decision-making.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
Parkinson’s Disease: Advances In Clinical Therapy
Advance your clinical framework with the latest regenerative neuroscience on Parkinson's, Alzheimer's, and neuroplasticity from a world-class researcher.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
Exploring Molecular Hydrogen in Clinical Practice
Explore how molecular hydrogen supports antioxidant, anti-inflammatory, and metabolic pathways—and learn simple, clinically actionable ways to integrate hydrogen water and gas into patient care safely and effectively.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
Functional Medicine Approaches to Peripheral Neuropathy
Elevate your peripheral neuropathy practice with advanced pattern recognition, lab mastery, and integrative treatment across all major etiologies.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
Molecular Hydrogen Neuroprotection
A 1-credit ISCN lecture exploring molecular hydrogen as a neuroprotective therapy, focusing on oxidative stress reduction, mitochondrial support, and emerging clinical applications.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
%
Off
<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 120 120"><path stroke="currentColor" stroke-linecap="round" stroke-width="6" d="M115.6 89.143V30.857c0-6.411-5.231-11.657-11.625-11.657h-88.35C9.231 19.2 4 24.446 4 30.857v58.286C4 95.554 9.231 100.8 15.625 100.8h88.35c6.394 0 11.625-5.246 11.625-11.657ZM53.08 78.48c-3.09 2.066-7.23-.155-7.23-3.88V45.399c0-3.724 4.14-5.945 7.23-3.88L74.92 56.12c2.761 1.846 2.761 5.914 0 7.76L53.08 78.48Z"/></svg>
The Therapeutic Effects and Clinical Applications of Molecular Hydrogen for Neurological Health
A 1-credit exploratory course examining molecular hydrogen’s neuroprotective mechanisms, redox regulation, nitric oxide synergy, and emerging clinical applications in neurological health.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
$
/hr.
|
hours
Regenerative therapies encompass a range of treatments designed to support or restore the body's natural repair processes. The field is evolving rapidly, with applications spanning musculoskeletal, neurological, and other domains, and the quality of evidence varies considerably across them — from well-studied to genuinely early-stage. This variability is the central theme, and it's why honest framing matters so much here. An integrative, evidence-informed approach focuses on where regenerative strategies are genuinely indicated and supported, applies them within a broader care plan, and communicates realistic expectations — distinguishing legitimate clinical application from the overpromising that pervades this space. It treats regenerative options as one tool among many rather than a standalone promise of cure. For patients who have encountered confident marketing but little candor, that measured, transparent stance is itself part of the value: it helps them make an informed decision rather than a hopeful gamble. That measured, transparent stance is itself part of the value, helping patients make an informed decision rather than a hopeful, costly gamble.
Regenerative approaches are considered across a range of clinical situations:- Musculoskeletal injury or degeneration- Slow or incomplete tissue healing- Conditions where supporting natural repair is a treatment goal- Situations where conventional options have been exhausted- Cases requiring careful evaluation of evidence and appropriateness- Care plans where regenerative strategies complement other treatments
Regenerative therapies aim to influence the body's own repair biology — supporting cellular signaling, tissue healing, and recovery. The underlying science is legitimate and steadily advancing, but the strength of evidence differs markedly by application and by indication. The core challenge is matching therapy to evidence: applying these approaches where they are genuinely supported, with honest expectations, while avoiding the overpromising that pervades so much of the field's marketing. A grounded, integrative framework — one that places regenerative strategies within a broader, individualized care plan rather than treating them as a standalone cure — is what distinguishes responsible clinical application from hype, and protects the patient making the decision.
What to expect
Do you work with companies outside North America?
Yes. We run programs internationally and have active partnerships across the US, Europe, and Asia-Pacific. Our Haarlem, Cape Canaveral, Minnetonka, and Adelaide venues reflect the global reach of our community.
Can we sponsor an existing course instead of creating a new one?
Yes — this is a common "Advertise With CI" arrangement. Sponsoring a module, livestream, or course gives you aligned visibility without the lead time of building new content. Get in touch to discuss available opportunities.
How is pricing structured?
Partnerships are priced based on scope, reach, and scale. We share specifics during a discovery call once we understand what you're looking to accomplish.
Who owns the content we co-create?
IP arrangements vary by partnership. For most "Create With CI" engagements, CI retains ownership of the curriculum format and delivery infrastructure while partners retain rights over their branded content and any proprietary clinical content they bring. We detail this in every agreement.
Do you offer exclusivity?
Within certain partnership tiers and campaign windows, yes. Exclusivity is always negotiated per engagement and reflects the scale of commitment.
How long is a typical engagement?
t depends on the partnership type. Advertising and sponsorships can start within weeks. Custom content co-creation ("Create With CI") typically takes 3–6 months from agreement to release. On-site program delivery ("Bring CI To You") varies by scale — a single-day presentation can be arranged in a month or two; a multi-module program may take a full year to plan and execute.
Not sure where to start?
Take our short guided quiz to find the right entry point based on your experience, license, and goals.